Randeep Guleria: Latest News

All news where Randeep Guleria is mentioned

18.03.2023 / 13:11

‘Must be seriously worried,’ experts caution as India reports 76 COVID XBB 1.16 variants

#Arcturus could succeed to wade through the ‘sturdy’ population immunity of Indians that successfully resisted the onslaught of variants like BA.2.75, BA.5, BQs, XBB.1.5, then whole world must be seriously worried!! pic.twitter.com/PZYuM7hD7Q Though XBB.1.16 is capable of turning off both innate & adaptive responses, I wud be surprised if it cud generate a major surge here. All will depend on how well population immunity would resist this at the backdrops of differentially imprinted immunity & its waning overtime! he also tweeted. Meanwhile, Dr Randeep Guleria, former AIIMS director and the chairman of the Institute of Internal Medicine, Respiratory and Sleep Medicine, Director-Medical Education at Medanta, and former AIIMS director said that the rise in COVID cases seems to be driven by the XBB 1.16 variant, but most cases are not severe, so there is no need to panic as of now.

Randeep Guleria India covid-19 experts prevention infection medicines reports Immunic

Self-testing could mask real Covid number, sales increase to 15% in April: Report

COVID-19 testing which give faster results in just 10 minutes. Other approved are Mylab Discovery’s Coviself that gives results in 15 minutes, Abbott Rapid’s Panbio COVID-19 Antigen rapid test device, Meril Diagnostics’ CoviFind, Angstrom Biotech’s Angtech, Healgen Scientific Limited’s CliniTest, SD Biosensor Healthcare’s ULTRA Covi-Catch SARS-CoV-2 home test, Nulife Care’s AbCheck. Meanwhile, India registered 9,111 new coronavirus infections, and the count of active cases in the country has increased to 60,313, according to Union Health Ministry data updated on 17 April.

Randeep Guleria India city Delhi hospital covid-19 death testing vaccine mask infection

Delhi's COVID-19 positivity rate rises to highest in 15 months; schools, hospitals revert to mask mandates

ALSO READ: 'Its not a panic situation': Dr Randeep Guleria on rising COVID-19 cases Meanwhile, AIIMS Delhi has issued an advisory making it mandatory for all hospital staff to wear masks inside the premises and follow Covid-appropriate behaviour. The notice issued on April 8 also urged employees to avoid gatherings of five or more persons in canteens or offices and asked those at higher risk to take extra precautions.

Randeep Guleria India city Delhi hospital covid-19 gatherings mask Department Health

'Its not a panic situation': Dr Randeep Guleria on rising COVID-19 cases

#WATCH | Patna, Bihar: The Covid19 cases have increased, but hospital admissions haven't increased. It's not a panic situation. High-risk groups and the elderly need to take extra precautions: Dr Randeep Guleria, former AIIMS-Delhi Director pic.twitter.com/vlKyrEl49Z Earlier in the day, the Union Health Ministry data said that India's active caseload has gone up to 53,720.

Randeep Guleria India city Delhi hospital covid-19 experts pandemic mask infection Health

India records a spike in Covid-19 cases. All you need to know

XBB 1.16 variant could be behind it. However, the country has started taking precautionary measures to prevent a further increase in Covid-19 cases. Prime Minister Narendra Modi also held a meeting to review the situation. Former AIIMS director Dr.

Narendra Modi Randeep Guleria India hospital virus covid-19 death testing prevention infection

Tamil Nadu health dept to conduct 1,000 fever camps on Mar 10 amid rising cases

The Medical and Family Welfare Minister of Tamil Nadu, Ma Subramanian, announced on Tuesday that the state's health department will conduct more than 1,000 fever camps on March 10. This decision was made due to a reported increase in fever cases among the public in the state. Subramanian added, "Tamil Nadu Health Department to conduct a mega fever camp where 1000 camps all over the state to be conducted on 10th March from 9 AM.

Tamil Nadu Randeep Guleria India state Health city Chennai virus experts infection medicines Department reports

H3N2 also spreads like Covid, says ex-AIIMS chief Randeep Guleria

influenza. We need to wear a mask if we're going to crowded places.

Randeep Guleria India hospital virus vaccine mask symptoms patient Health

COVID cases are rising: How do we make sense of the sudden spike. Explained in 4 points

Even as we assume that COVID-related risks have significantly reduced, the cases are rising again. India on Monday logged 12,781 fresh COVID-19 cases that pushed its infection tally to 4,33,09,473, while the daily positivity rate went past 4% for the first time in 130 days.

Randeep Guleria K.Arora India city Delhi experts vaccine infection

WHO report on excess Covid-19 deaths in India: What top health experts say

PTI report.

Niti Aayog Randeep Guleria Balram Bhargava India covid-19 death reports

From AIIMS director to Niti Aayog member, top India's experts reject WHO's Covid death data

WHO via diplomatic channels with data that we don't agree with the methodology followed for us," he added.

Niti Aayog Randeep Guleria India city Delhi covid-19 death reports

XE COVID variant: Your kids not vaccinated yet? Follow these rules if you're sending them to school

children can contract the COVID like all adults but its severity will remain low. Hence, there is no need to panic, but it is important to remain careful.

Randeep Guleria city New Delhi India vaccine symptoms Waves

COVID among Children: With XE variant circulating, should you send kids to school? AIIMS chief answers

With some children getting Covid infection soon after schools reopened, health experts pointed out there is no need to panic as children usually show mild symptoms but stressed that the children who are eligible to get vaccinated against Covid must get the jab. They further urged all to maintain COVID-appropriate behaviour.

Randeep Guleria India covid-19 vaccine infection

Delhi Covid update: DDMA meeting next week; mandatory mask rule likely to be implemented

DDMA may reconsider its earlier decision to lift the fine on not wearing face masks in public places as a lot of people have stopped using them despite the increase in infections.

Easter Sunday Satyendar Jain Anil Baijal Niti Aayog Randeep Guleria Kailash Gahlot India city Delhi testing mask Health

Mandaviya reviews public health preparedness for covid-19 case surge in China & other countries

NEW DELHI :

Randeep Guleria Balram Bhargava Rajesh Bhushan Mansukh Mandaviya China city New Delhi India Hong Kong covid-19 infection Health

India calls for aggressive genome sequencing as Covid cases spike in Asia, Europe

Covid-19 cases are spiking in some Asian and European countries again.

Tedros Adhanom Ghebreyesus Health Organisation Niti Aayog Randeep Guleria Balram Bhargava Rajesh Bhushan Rajesh Gokhale China Singapore India Hong Kong Vietnam covid-19 Government Health

Covid-19 update: India logs 10,273 fresh Covid-19 cases, 243 deaths in last 24 hours

#COVID19 cases, 20,439 recoveries, and 243 deaths in the last 24 hours.Active case: 1,11,472 (0.26%)Daily positivity rate: 1.00%Total recoveries: 4,22,90,921Death toll: 5,13,724 Total vaccination: 1,77,44,08,129 pic.twitter.com/Qtyuy9lm72

Satyendar Jain Arvind Kejriwal Anil Baijal Manish Sisodia Niti Aayog Randeep Guleria Balram Bhargava Kailash Gahlot India city Delhi covid-19 death vaccine

Long COVID: UK study reveals symptoms, effects, precautions. Take note

long COVID. Some experts suggest such symptoms can even be seen in patients who have even suffered mild to moderate infections.

Randeep Guleria What Aiims India Britain experts symptoms patient

Omicron India: Govt 'watching' emerging Covid cases carefully, says Dr VK Paul

ANI.Health Minister has said in the parliament, the need, the timing, and the nature of boosting if any will be based on the scientific decision, thinking: Dr VK Paul, Member-Health, Niti Aayog on Booster dose #COVID19 pic.twitter.com/bPhJcuVD44

Randeep Guleria India city Delhi state While vaccine Coronavirus Health

Covid pandemic showed how technology can be game-changer: AIIMS chief Randeep Guleria

(With inputs from agencies)Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Randeep Guleria India pandemic information

AIIMS 'lighthouse' of health sector; launch of 22 AIIMS soon: Health minister

(AIIMS) 66th Foundation Day, the Union Health Minister said that the country's health budget has been increased to ₹2.40 lakh crore under PM Modi's leadership.

Randeep Guleria Bharati Pravin Pawar India city Delhi covid-19 information Health

Covid vaccine for children may be available by September in India: ICMR-NIV director

vaccinated against Covid-19 by September this year, said Priya Abraham, the director of Indian Council of Medical Research (ICMR)’s National Institute of Virology (Pune).

Randeep Guleria India city Pune covid-19 vaccine Health

Second Covid wave not over, third one depends on people's behaviour: AIIMS Director Randeep Guleria

ANI, Dr Guleria said, “I would suggest that people should understand that the second wave of the pandemic is not over yet. Daily, we are getting more than 40,000 cases. It is important for everyone to follow COVID-appropriate behaviour. If we follow this, then another wave will not come."

Randeep Guleria India covid-19 pandemic Waves behaviour

Do you need Covid vaccine booster shots and when? AIIMS chief answers

need a booster with a second-generation Covid-19 shot, said Dr Randeep Guleria, the chief of All India Institute of Medical Sciences (AIIMS).

Randeep Guleria India covid-19 vaccine Health

When can we expect Covid vaccines for children in India? AIIMS chief Guleria has an answer

Covaxin trials for children are presently underway and the results are expected to be released by September, AIIMS director Randeep Guleria said today, news agency ANI tweeted.

Randeep Guleria India covid-19 vaccine Government

How Covid-19 affects children, govt explains amid possible third wave concerns

There is not data yet to show that children will be seriously infected

Randeep Guleria city New Delhi India covid-19 infection Health Waves

Covid vaccine for children above 2 years: When will India have one? What AIIMS chief Guleria says

COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will lead to approvals so that there is a vaccine for children in the country by September-October.

Randeep Guleria What Aiims India city Delhi covid-19 pandemic vaccine

These three things are crucial to avoid third wave of Covid-19: AIIMS chief Dr Guleria

ANI, AIIMS Delhi Director Dr Randeep Guleria has said that Covid-19 cases have come down and the mistake of not strictly following COVID protocols, made after the first wave, should not be repeated.

Randeep Guleria India city Delhi covid-19 vaccine Waves

AIIMS doctor highlights 2 important factors for future Covid-19 waves

ANI, Nischal revealed that COVID-19 waves will depend on two important factors; one is virus-related and the second is human-related.

Randeep Guleria India covid-19 infection Waves

India looking forward to WHO approval for home-grown covid vaccine Covaxin

NEW DELHI : India is looking forward to the World Health Organization (WHO) approving and recognizing India’s indigenously developed anti-covid vaccine, Indian foreign secretary Harsh Vardhan Shringla said on Thursday.In his address to the WHO's “South-East Asia Regional Health Partners’ Forum on COVID-19", Shringla also underlined India’s intention to participate in international regeneration efforts as the pandemic wanes, through building newer and more resilient supply chains.The meet was attended by Ajay Seth, secretary, department of economic affairs; Rajesh Bhushan, health secretary; and Randeep Guleria, director, All India Institute of Medical Sciences, besides participants from Sri Lanka, Nepal and Bhutan.Shringla said covid-19 had

Randeep Guleria Vardhan Shringla city New Delhi India Sri Lanka Nepal Bhutan covid-19 pandemic vaccine

Why is long covid turning out to be a fresh concern?

What is long covid and how prevalent is it?Long covid refers to the phenomena where people continue to experience the effects of covid-19 for weeks or months. According to Randeep Guleria, director of All India Institute of Medical Sciences, if symptoms persist for 4-12 weeks, it should be regarded as post-covid acute syndrome, while if symptoms persist for longer than 12 weeks, it should be marked as long covid.

Randeep Guleria India symptoms patient why

First batch of covid-19 therapy drug 2-DG handed over to health minister

NEW DELHI : Defence minister Rajnath Singh on Monday handed over to health minister Harsh Vardhan the first batch of the covid-19 therapy drug, 2-deoxy-D-glucose (2-DG) that reduces supplemental oxygen dependence and helps in faster recovery of hospitalized patients.A second batch of the drug was handed over to Randeep Guleria, director, All India Institute of Medical Sciences (AIIMS), and a third consignment to Lt Gen.

Randeep Guleria Rajnath Singh city New Delhi India hospital covid-19 medicines

COVID-19 cases in India hopefully stabilizing, as daily deaths stay near 4,000: officials

India reported its smallest daily increase in coronavirus infections in nearly three weeks on Saturday, with deaths still near the 4,000-mark, but federal health officials said cases and fatalities are rapidly stabilizing in this wave of the pandemic.The overall rate of positive cases per tests had dipped to 19.8 per cent this week from 21.9 per cent last week, federal health officials said in a briefing, but warned that cautiousness must continue.Randeep Guleria, director of AIIMS Hospital in Delhi warned that secondary infections like mucormycosis or “black fungus” were adding to India’s mortality rate with states having reported more than 500 cases recently in COVID-19 patients with diabetes.

Randeep Guleria India city Delhi covid-19 infection

Covid vaccines will be available in large amounts in 2 months: Delhi AIIMS Director Randeep Guleria

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Randeep Guleria India city Delhi information vaccine

Covid is mild for most; hoarding of oxygen, medicines creating panic: AIIMS chief

oxygen in homes is creating panic and causing a shortage of these medicines, said Dr Randeep Guleria, the director of All India Institute of Medical Sciences, on Sunday."Covid-19 is a mild infection and 85-90% of people will only suffer from cold, fever, sore throat and body ache.

Randeep Guleria India hospital infection patient

'India's Covid-19 positivity rate can be brought down to less than 5% in 3 weeks if...': AIIMS doctor

COVID appropriate behaviour," Dr Wig said while addressing a joint conversation on issues related to the Covid-19 situation with the Director of AIIMS (Delhi ) Dr Randeep Guleria, Director General of Health Services (DGHS), Dr Sunil Kumar, and Chairman of Medanta Dr Naresh Trehan.He further highlighted that severe restrictions have to implemented to pull down the positivity rate of COVID-19 cases."All district officials must monitor district's positivity rate and aim to keep it below 1-5 per cent. Mumbai had 26 per cent positivity rate at one point but after severe restrictions, it came down to 14 per cent.

Randeep Guleria Sunil Kumar India city Mumbai city Delhi covid-19 doctor Coronavirus

Covid-19 treatment explained by Naresh Trehan, Devi Shetty and Randeep Guleria

Covid-19, including judicious use of Remdesivir and Oxygen. Here's what they say:On the use of Oxygen in covid treatment-AIIMS Director Dr.

Randeep Guleria Devi Shetty India hospital doctor patient

Covid surge: Oxygen shortage reported in several Delhi hospitals

news agency ANI today.Meanwhile, five hours of oxygen left at Delhi's Sir Ganga Ram Hospital as 58 COVID-19 patients are admitted there including 10 in the intensive care unit (ICU).

Manish Sisodia Ganga Ram Randeep Guleria India city Delhi hospital patient

AIIMS chief on why India seeing spike in Covid cases. He also cites a warning

New Delhi: People not adhering to COVID-appropriate behaviour and the circulation of highly infectious strains of SARS-COV-2 could be the primary reasons behind the surge in coronavirus infections in India, AIIMS Director Dr Randeep Guleria said on Monday.He also warned that if the situation is not reversed, then the galloping infection rate will eventually cause a huge strain on the country's healthcare system. He sought stricter enforcement of COVID-appropriate behaviour on the ground level by the administration and authorities."Around February, when cases started to decrease, people became lax towards following COVID-appropriate behaviour as they thought the virus had become ineffective."People are taking the disease lightly now.

Randeep Guleria city New Delhi India covid-19 infection strain why

AIIMS chief calls for PPP to rollout large-scale COVID-19 vaccination programme

New Delhi: Terming the recent drop in COVID-19 cases in the country as a "small window of opportunity", AIIMS Director Randeep Guleria on Saturday called for a public-private partnership (PPP) for rollout of the COVID-19 vaccination programme at a large scale.Speaking at an AIMA event here, Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease.He noted that there was a need to put healthcare at the centrestage and not consider it only as a service sector."As far as vaccination is concerned there is still a lot to do and I think there has to be more private public partnership," the All India Institute of Medical Sciences (AIIMS) director said.There is a need to

Randeep Guleria city New Delhi India covid-19 vaccine

AIIMS Director Dr Randeep Guleria receives second dose of Covid vaccine

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Randeep Guleria vaccine

Second round of Covid vaccine booster shot in India starts today: 10 things to know

coronavirus vaccination on Saturday for the beneficiaries who were given jabs at the beginning of the nationwide inoculation drive on 16 January.After a sluggish start, since the exercise was kicked off, the vaccination drive had picked up pace in the last several days.AIIMS Director Dr Randeep Guleria and NITI Aayog's VK Paul, who were among the first ones to take the Covid-19 vaccine, are expected to receive the second dose, which needs to be taken 28 days after the first one.Everything you need to know about 2nd Covid vaccine dose:1) According to the doctors, the second round of Covid-19 vaccine booster dose is to be given to a beneficiary after a gap of 28 days.2) However, experts have clarified that the second shot can be taken anytime

Randeep Guleria India covid-19 vaccine doctor Coronavirus

Covid-19 vaccination drive kicks off in India, doctors, nurses and sanitation workers vaccinated across India

New Delhi: With India rolling out its covid-19 inoculation drive on Saturday, lakhs of doctors, nurses and frontline workers across the country got covid-19 vaccines on the first day. While a sanitation worker named Manish Kumar became the first recipient of the covid-19 vaccine drive at All India Institute of Medical Sciences (AIIMS), New Delhi, Dr Randeep Guleria, Director AIIMS and Dr V.K.

Randeep Guleria city New Delhi India hospital covid-19 vaccine

'Want to show COVID vaccine is safe,' says AIIMS machine operator as he receives first Covaxin shot

NEW DELHI: Manish Kumar was surrounded by television cameras and microphones for more than an hour at the All India Institute of Medical Sciences (AIIMS), with journalists waiting to take a byte from him.As journalists jostled to get a quote from the 34-year-old, they created a crowd that defied most social distancing norms of the covid-19 pandemic, albeit while wearing masks.In fact, the gathering was similar to those present with the likes of newsmakers like Union health minister Harsh Vardhan, NITI Aayog member Vinod K.

Niti Aayog Randeep Guleria city New Delhi India hospital covid-19 vaccine

AIIMS Director Dr Randeep Guleria receives Covid-19 vaccine in Delhi

#WATCH | AIIMS Director Dr Randeep Guleria receives COVID-19 vaccine shot at AIIMS, Delhi. pic.twitter.com/GFvZ2lgfj3Guleria was the third person to take the shot.

Randeep Guleria India city Delhi covid-19 vaccine sanitizer Coronavirus

India will have Covid-19 vaccine within days: AIIMS director Randeep Guleria

AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days."This is very good news that AstraZeneca got approval for its vaccine by UK regulatory authorities. They have robust data and in India and the same vaccine is being developed by the Serum Institute of India.

Randeep Guleria India Britain city Delhi covid-19 2020 vaccine

New coronavirus strain: No need to change existing treatment protocol, says NTF

Covid-19 convened by ICMR on Saturday concluded that there is no need to change the existing treatment protocol in view of mutations emerging in the coronavirus strain.The meeting was held to discuss evidence-based modifications in testing, treatment and surveillance strategies after new variants of coronavirus was recently discovered in the UK and Nigeria.Convened under co-chairpersonship of professor Vinod Paul, a member Niti Aayog, and professor Balram Bhargava, the secretary at the Department of Health Research & Director General ICMR.

Niti Aayog Randeep Guleria Vinod Paul Balram Bhargava India Britain Nigeria covid-19 Coronavirus

Govt will bear the entire cost of Covid-19 vaccination: Guleria

New Delhi: India’s Covid-19 vaccination programme will done at the government's expense, said Dr. Randeep Guleria, director, All India Institute of Medical Sciences (AIIMS) on Monday.

Randeep Guleria city New Delhi India covid-19 vaccine Government

India’s virus cases cross 10 million as new infections dip

NEW DELHI – India’s confirmed coronavirus cases have crossed 10 million with new infections dipping to their lowest levels in three months, as the country prepares for a massive COVID-19 vaccination in the new year. Additional cases in the past 24 hours dropped to 25,152 from a peak of nearly 100,000 in mid-September.

Randeep Guleria city New Delhi Usa India vaccine infection Health Infections

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0